Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Appointed director
Notes underwriting agrmnt
|
|
Avant Diagnostics, Inc (OREO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2020 |
SC 13D
| Avant Diagnostics, Inc reports a 99% stake in ONCBIOMUNE PHARMACEUTICALS, INC. |
| 06/15/2020 |
3
| Avant Diagnostics, Inc (10% Owner) has filed a Form 3 on OncBioMune Pharmaceuticals, Inc |
| 05/13/2019 |
REVOKED
| Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]: |
| 04/09/2019 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 03/26/2019 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu... |
| 03/13/2019 |
10-Q
| Quarterly Report for the period ended December 31, 2018 |
| 03/01/2019 |
10-K
| Annual Report for the period ended September 30, 2018 |
| 02/06/2019 |
8-K
| Quarterly results |
| 01/30/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
| 01/09/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2018 |
| 12/28/2018 |
10-Q
| Quarterly Report for the period ended December 31, 2017 |
| 12/04/2018 |
10-K
| Annual Report for the period ended September 30, 2017 |
| 12/04/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2017 |
| 10/26/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/23/2018 |
10-Q
| Quarterly Report for the period ended March 31, 2017 |
| 10/23/2018 |
10-Q
| Quarterly Report for the period ended December 31, 2016 |
| 10/10/2018 |
4
| Busch Jeffrey (Director) has filed a Form 4 on Avant Diagnostics, Inc|
Txns:
| Granted 50,000 preferred shares
@ $1, valued at
$50k
|
|
| 09/24/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/21/2018 |
3
| DeLaO Andrew John (Director) has filed a Form 3 on Avant Diagnostics, Inc |
| 09/14/2018 |
3
| SHROTRIYA RAJESH C MD (Director) has filed a Form 3 on Avant Diagnostics, Inc |
| 09/14/2018 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 09/11/2018 |
4
| RUXIN MICHAEL I (CEO) has filed a Form 4 on Avant Diagnostics, Inc|
Txns:
| Granted 25,000 preferred shares
@ $1, valued at
$25k
|
|
| 08/28/2018 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu... |
| 08/27/2018 |
10-K
| Annual Report for the period ended September 30, 2016 |
| 07/25/2018 |
3
| Cole Henry (Director) has filed a Form 3 on Avant Diagnostics, Inc |
| 06/14/2018 |
8-K
| Appointed a new director |
| 06/12/2018 |
3
| Busch Jeffrey (Director) has filed a Form 3 on Avant Diagnostics, Inc |
| 06/05/2018 |
3
| RUXIN MICHAEL I (CEO) has filed a Form 3 on Avant Diagnostics, Inc |
| 06/04/2018 |
3
| Brugmann John Edward (Director) has filed a Form 3 on Avant Diagnostics, Inc |
| 05/25/2018 |
8-K
| Certificate of designation filed, Appointed a new director|
Docs:
|
"Certificate of Designation of Preferences, Rights and Limitations of Series A Preferred Stock, filed with the Nevada Secretary of State on May 25, 2018",
"Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred Stock, filed with the Nevada Secretary of State on May 25, 2018",
"Form of Promissory Note issued to 2016 Investors",
"Form of Convertible Promissory Note issued to Coastal Investment Partners, LLC",
"Form of Promissory Note issued to Black Mountain Equity Partners LLC",
"Form of Subscription Agreement for the May 2018 Financing",
"Form of Exchange Agreement by and between the Company and the 2017 Investors and the 2016 Investors",
"Form of Termination Agreement, by and between the Company and the 2017 Investors",
"Exchange Agreement, by and between the Company and Coastal Investment Partners, LLC",
"Termination Agreement, by and between the Company and Coastal Investment Partners, LLC" |
|
| 04/06/2018 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ... |
| 01/03/2018 |
8-K
| Other Events |
| 12/18/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/29/2017 |
3
| TRAPP ROBERT H (Director) has filed a Form 3 on Avant Diagnostics, Inc |
|
|
|